Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonetheless.
Paraskevas
Kosmas I
KI
Department of Vascular Surgery, Red Cross Hospital, 24 Al. Papagou Street, 14122 Athens, Greece.
Mikhailidis
Dimitri P
DP
D001021:Aortic Valve / Q000187:drug effects* / Q000473:pathology / Q000601:surgery*; D001705:Bioprosthesis; D002114:Calcinosis / Q000209:etiology / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D011474:Prosthesis Design; D011475:Prosthesis Failure
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors